Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

Digital health company Better Therapeutics has submitted its lead prescription digital therapeutic (DTx) BT-001 to the FDA, seeking approval for use by adults with type 2 diabetes (T2D).

As a discretionary fund management team, full service is our nature, we are excited to offer our full service for our Multi Asset Fund Range as well. Each fund is aligned to a Morningstar risk ...

We have a wide range of Delivery Options available, depending on the value of your parcel and budget. Select from our 2-3 Day Saver Service or our Next Working Day options at the Checkout. This will ...

Sundaram Multi Pap Ltd. key Products/Revenue Segments include Student Books/Exercise Books, Traded Goods for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a ...

Mid-cap, small-cap stocks likely to see further time correction: Shridatta Bhandwaldar, Canara Robeco MF MF Tracker: Canara Robeco Emerging Equities Fund turns Rs 10,000 SIP to Rs 2 crore in 20 years ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...